Core Laboratories Inc. (CLB) Gains on Sequential Revenue Growth and Solintec Acquisition

Ariel Investments, an investment management company, released its “Ariel Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund delivered a +3.22% return in the fourth quarter of 2025, performing roughly in line with both the Russell 2500 Value Index (+3.15%) and the Russell 2000 Value Index (+3.26%), as U.S. equities posted a modest quarterly gain despite earlier volatility marked by a sharp April sell-off, an extended government shutdown, and rising job cuts. For the trailing one-year period, the Fund advanced 14.15%, outperforming the Russell 2500 Value Index’s +12.73% and the Russell 2000 Value Index’s +12.59% return, while its 5- and 10-year average annual returns stood at +9.36% and +9.51%, respectively. Management attributed performance to resilient corporate earnings, easing inflation, and rising expectations for more accommodative monetary policy. Continued enthusiasm around artificial intelligence and cloud infrastructure also supported markets, although gains remained concentrated in a narrow group of large-cap stocks. Looking ahead to 2026, the firm maintains a measured and cautious outlook. It pointed to geopolitical risks, fiscal constraints, labor market dynamics, and elevated market concentration as potential sources of volatility. At the same time, management reaffirmed its long-term, bottom-up approach, emphasizing strong balance sheets, durable fundamentals, and valuation discipline to navigate shifting market leadership. In addition, please check the Fund’s top five holdings to know its best picks in 2025.

In its fourth-quarter 2025 investor letter, Ariel Fund highlighted stocks like Core Laboratories Inc. (NYSE:CLB). Core Laboratories Inc. (NYSE:CLB) provides reservoir description and production enhancement services that help oil and gas companies improve recovery from their energy assets. The one-month return of Core Laboratories Inc. (NYSE:CLB) was -15.49% while its shares traded between $9.72 and $20.36 over the last 52 weeks. On March 5, 2026, Core Laboratories Inc. (NYSE:CLB) stock closed at approximately $16.11 per share, with a market capitalization of about $735.76 million.

Ariel Fund stated the following regarding Core Laboratories Inc. (NYSE:CLB) in its Q4 2025 investor letter:

Oil services company, Core Laboratories (NYSE:CLB) also traded higher after reporting another quarter of sequential revenue growth, propelled by strong global demand for its proprietary services and products. Operating income, margins and EPS improved, while the Company enhanced its international presence through the acquisition of Brazil-based Solintec. CLB also strengthened its financial position by reducing leverage to a nine-year low and returning capital to shareholders through dividends and buybacks. With a strong balance sheet and a disciplined focus on free cash flow, debt reduction and improving return on invested capital, the company is positioning itself for long-term growth. In our view, CLB’s global footprint and specialized services offer an attractive way to participate in future energy development cycles.

Core Laboratories Inc. (NYSE:CLB) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. As per our database, 15 hedge fund portfolios held Core Laboratories Inc. (NYSE:CLB) at the end of the fourth quarter, which was 21 in the previous quarter. While we acknowledge the risk and potential of Core Laboratories Inc. (NYSE:CLB) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

In another article, we covered Core Laboratories Inc. (NYSE:CLB) and shared the company's earnings call transcript. In addition, please check out our hedge fund investor letters Q4 2025 page for more investor letters from hedge funds and other leading investors.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None. This article is originally published at Insider Monkey.